{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:48:32Z","timestamp":1791312512170,"version":"4.3.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T00:00:00Z","timestamp":1677715200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","award":["NCT03409107"],"award-info":[{"award-number":["NCT03409107"]}],"id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","award":["205270"],"award-info":[{"award-number":["205270"]}],"id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.kint.2023.02.019","type":"journal-article","created":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T21:04:13Z","timestamp":1677704653000},"page":"1180-1192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["The ASCEND-NHQ randomized trial found positive effects of daprodustat on hemoglobin and quality of life in patients with non-dialysis chronic kidney disease"],"prefix":"10.1016","volume":"103","author":[{"given":"Kirsten L.","family":"Johansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander R.","family":"Cobitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain C.","family":"Macdougall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato D.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregorio T.","family":"Obrador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csaba P.","family":"Kovesdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rubeen","family":"Israni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivekanand","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Okoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Sprys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivinder","family":"Jolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alistair C.","family":"Lindsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Purav","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo Refoios","family":"Camejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Keeley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borut","family":"Cizman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2023.02.019_bib1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000500668","article-title":"Fatigue in nondialysis chronic kidney disease: correlates and association with kidney outcomes","volume":"50","author":"Gregg","year":"2019","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.kint.2023.02.019_bib2","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s41687-020-00215-8","article-title":"Symptoms and impacts in anemia of chronic kidney disease","volume":"4","author":"Mathias","year":"2020","journal-title":"J\u00a0Patient Rep Outcomes"},{"key":"10.1016\/j.kint.2023.02.019_bib3","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1136\/bmj.300.6724.573","article-title":"Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis","volume":"300","year":"1990","journal-title":"BMJ"},{"key":"10.1016\/j.kint.2023.02.019_bib4","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0272-6386(12)80290-3","article-title":"Double-blind, placebo-controlled study of the therapeutic use of recombinant human erythropoietin for anemia associated with chronic renal failure in predialysis patients","volume":"18","year":"1991","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2023.02.019_bib5","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/0272-6386(95)90122-1","article-title":"Health-related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patients","volume":"25","author":"Revicki","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2023.02.019_bib6","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa062276","article-title":"Normalization of hemoglobin level in patients with chronic kidney disease and anemia","volume":"355","author":"Dr\u00fceke","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2023.02.019_bib7","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2215\/CJN.06450710","article-title":"Darbepoetin alfa impact on health status in diabetes patients with kidney disease: a randomized trial","volume":"6","author":"Lewis","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2023.02.019_bib8","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1056\/NEJMoa065485","article-title":"Correction of anemia with epoetin alfa in chronic kidney disease","volume":"355","author":"Singh","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2023.02.019_bib9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/ckj\/sfy014","article-title":"Daprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants on hemodialysis","volume":"12","author":"Meadowcroft","year":"2019","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.kint.2023.02.019_bib10","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/ckj\/sfx140","article-title":"Adherence to medication in patients with chronic kidney disease: a systematic review of qualitative research","volume":"11","author":"Mechta Nielsen","year":"2018","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.kint.2023.02.019_bib11","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJMoa2035938","article-title":"Vadadustat in patients with anemia and non-dialysis-dependent CKD","volume":"384","author":"Chertow","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2023.02.019_bib12","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1056\/NEJMoa2113380","article-title":"Daprodustat for the treatment of anemia in patients not undergoing dialysis","volume":"385","author":"Singh","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2023.02.019_bib13","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1056\/NEJMoa2025956","article-title":"Safety and efficacy of vadadustat for anemia in patients undergoing dialysis","volume":"384","author":"Eckardt","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2023.02.019_bib14","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1681\/ASN.2020081150","article-title":"Roxadustat for treating anemia in patients with CKD not on dialysis: results from a randomized phase 3 study","volume":"32","author":"Fishbane","year":"2021","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2023.02.019_bib15","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1093\/ndt\/gfab057","article-title":"Roxadustat for the treatment of anemia in chronic kidney disease patients not on dialysis: a phase 3, randomized, double-blind, placebo-controlled study (ALPS)","volume":"36","author":"Shutov","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2023.02.019_bib16","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1093\/ndt\/gfq336","article-title":"Target haemoglobin to aim for with erythropoiesis-stimulating agents: a position statement by ERBP following publication of the Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT) study","volume":"25","author":"Locatelli","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2023.02.019_bib17","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1186\/s12882-017-0688-1","article-title":"Renal association clinical practice guideline on anaemia of chronic kidney disease","volume":"18","author":"Mikhail","year":"2017","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.kint.2023.02.019_bib18","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1185\/030079906X132541","article-title":"Relationship between hemoglobin level and quality of life in anemic patients with chronic kidney disease receiving epoetin alfa","volume":"22","author":"Lefebvre","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.kint.2023.02.019_bib19","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1185\/030079907X178757","article-title":"Interpreting score differences in the SF-36 vitality scale: using clinical conditions and functional outcomes to define the minimally important difference","volume":"23","author":"Bjorner","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.kint.2023.02.019_bib20","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1185\/030079907X242502","article-title":"Association of anemia correction with health related quality of life in patients not on dialysis","volume":"23","author":"Alexander","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.kint.2023.02.019_bib21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12955-018-0933-8","article-title":"Measurement properties of the Short Form-36 (SF-36) and the Functional Assessment of Cancer Therapy\u2014Anemia (FACT-An) in patients with anemia associated with chronic kidney disease","volume":"16","author":"Finkelstein","year":"2018","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.kint.2023.02.019_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040455","article-title":"Understanding measurements of vitality in patients with chronic kidney disease: connecting a quality-of-life scale to daily activities","volume":"7","author":"Fukuhara","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2023.02.019_bib23","first-page":"279","article-title":"KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.kint.2023.02.019_bib24","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1056\/NEJMoa0907845","article-title":"A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease","volume":"361","author":"Pfeffer","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2023.02.019_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212184","article-title":"Quality of life and its predictors among patients with chronic kidney disease: a hospital-based cross sectional study","volume":"14","author":"Kefale","year":"2019","journal-title":"PLoS One"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253823001436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253823001436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:55:06Z","timestamp":1777474506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253823001436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0085253823001436"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2023.02.019","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The ASCEND-NHQ randomized trial found positive effects of daprodustat on hemoglobin and quality of life in patients with non-dialysis chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2023.02.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}